美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ProShares Ultra Health Care

57.95

+1.522.69%

成交量：1.50萬

成交額：86.75萬

市值：9,677.65萬

市盈率：- -

高：58.42

開：57.85

低：57.59

收：56.43

52周最高：64.60

52周最低：39.32

股本：167.00萬

流通股本：167.00萬

量比：2.05

換手率：0.90%

股息：0.71

股息率：1.22%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

強生：瑞布侖特法斯普羅聯合拉茲克魯澤治療一年，因治療相關事件停藥率不足1%

強生試驗性抑鬱症藥物未達中期研究主要目標

禮來表示，Foundayo已佔據美國口服減肥藥新患者市場的30%以上

Contineum與強生合作的抑鬱症藥物未能達到中期試驗目標

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/RXL"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RXL\",,,,,undefined,":{"symbol":"RXL","market":"US","secType":"STK","nameCN":"ProShares Ultra Health Care","latestPrice":57.95,"timestamp":1789416000000,"preClose":56.431,"halted":0,"volume":14958,"delay":0,"changeRate":0.026917828852935543,"floatShares":1670000,"shares":1670000,"eps":0,"marketStatus":"盤前交易","change":1.519,"latestTime":"09-15 04:41:13 EDT","open":57.85,"high":58.42,"low":57.59,"amount":867548.997126,"amplitude":0.014708,"askPrice":59.12,"askSize":100,"bidPrice":56.7,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":57.95,"sharesOutstanding":1700000,"nav":56.4373,"aum":94250291,"dividendRate":0.0122,"bidAskSpread":0.001712,"postHourTrading":{"tag":"盘后","latestPrice":57.95,"preClose":57.95,"latestTime":"19:30 EDT","volume":13,"amount":753.35,"timestamp":1789428601442,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.0450070868970025,"impliedVol":0.3024,"impliedVolPercentile":0.94},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RXL\",,,,,undefined,":{"symbol":"RXL","floatShares":1670000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.0450070868970025,"shares":1670000,"dividePrice":0.707,"high":58.42,"amplitude":0.014708,"preClose":56.431,"low":57.59,"week52Low":39.32,"pbRate":"--","week52High":64.595,"institutionHeld":0,"latestPrice":57.95,"eps":0,"divideRate":0.0122,"volume":14958,"delay":0,"ttmEps":0,"open":57.85,"prevYearClose":51.81,"prevWeekClose":56.431,"prevMonthClose":60.2649,"prevQuarterClose":53.0658,"fiveDayClose":60.6726,"twentyDayClose":58.1952,"sixtyDayClose":47.647},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RXL\",params:#limit:5,,,undefined,":[{"date":"2026-06-24","symbol":"RXL","amount":0.176774,"announcedDate":"2026-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-24","defaultRemindTime":1782307800000,"name":"ProShares Ultra Health Care","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-24","currency":"USD","dateTimestamp":1782273600000,"payDate":"2026-06-30"},{"date":"2026-03-25","symbol":"RXL","amount":0.144352,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"ProShares Ultra Health Care","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"RXL","amount":0.18376,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"ProShares Ultra Health Care","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"RXL","amount":0.203132,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"ProShares Ultra Health Care","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"RXL","amount":0.219278,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"ProShares Ultra Health Care","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RXL\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-29","value":0.006993,"currency":"USD"},{"executeDate":"2018-03-21","recordDate":"2018-03-22","paymentDate":"2018-03-28","value":0.066212,"currency":"USD"},{"executeDate":"2018-06-20","recordDate":"2018-06-21","paymentDate":"2018-06-27","value":0.050245,"currency":"USD"},{"executeDate":"2018-09-26","recordDate":"2018-09-27","paymentDate":"2018-10-03","value":0.053172,"currency":"USD"},{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2019-01-03","value":0.125412,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RXL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RXL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194954760","title":"強生：瑞布侖特法斯普羅聯合拉茲克魯澤治療一年，因治療相關事件停藥率不足1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194954760","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194954760?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:03","pubTimestamp":1789441392,"startTime":"0","endTime":"0","summary":"强生公司披露了一项令人振奋的临床数据——在接受瑞布仑特法斯普罗（Rybrevant Faspro）与拉兹克鲁泽（Lazcluze）联合治疗方案的患者群体中，经过整整一年的治疗周期，因治疗相关不良事件而选择终止用药的比例，竟低于1%。这一数字无疑为这款联合疗法在临床实践中的耐受性写下了一份极具说服力的注脚。换言之，绝大多数患者不仅能够坚持完成长期治疗，而且在整个过程中所承受的药物相关副作用，鲜少达到需要中断治疗的严重程度。强生方面强调，这一低停药率数据，从耐受性维度为该联合方案提供了坚实的循证支持，也进一步巩固了其在相关适应症治疗格局中的地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0069063385.USD","IE00B19Z3581.USD","LU2487616109.SGD","IHE","LU2133065610.SGD","BK4532","LU0345770308.USD","LU2756315664.SGD","SGXZ80539844.SGD","SG9999001176.SGD","IE00BDGV0183.EUR","IXJ","SG9999001440.SGD","SG9999001176.USD","IE0009355771.USD","LU2417539215.USD","LU0943347566.SGD","LU1162221912.USD","BK4592","IE00B42XCP33.USD","LU1059921491.USD","FHLC","IE00BN8TJ469.HKD","LU0689626769.HKD","LU2430703178.SGD","GDOC","LU0203347892.USD","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1221951129.SGD","LU0124676726.USD","LU0320765646.SGD","LU1894683348.USD","LU0994945656.USD","LU1674673428.USD","IE00B3T34201.USD","RXL","IE000F7OJYX1.SGD","LU0057025933.USD","IE000SO60NU8.SGD","LU0889566641.SGD","LU0787776722.HKD","BK4504","LU1066053197.SGD","LU1551013342.USD","LU0345769128.USD","LU0640476718.USD","LU1023059063.AUD","LU1551013425.SGD","BK4568","LU1585245621.USD","LU2471134952.CNY","LU0058720904.USD","LU1244550221.USD","LU2592432038.USD","MEDX","LU1043141396.HKD","LU2023250330.USD","JDOC","LU2129689431.USD","LU2430703095.HKD","FTXH","LU2089984988.USD","LU1629891620.HKD","LU1732799900.SGD","LU0792757196.USD","IE00B2B36J28.USD","SG9999002232.USD","LU1935042991.SGD","IE00BLSP4239.USD","LU2750360997.AUD","BK4585","LU2750360641.GBP","PJP","SG9999002224.SGD","LU0820561818.USD","LU1280957306.USD","LU0689472784.USD","SG9999013999.USD","LU1261432733.SGD","TRUH","LU0210536198.USD","LU0432979614.USD","IE00BKVL7J92.USD","LU0289739343.SGD","LU2236285917.USD","LU2213496289.HKD","LU2403377893.USD","IE00B3PB1722.GBP","LU1929549753.HKD","IE000MB6IJN5.SGD","LU1732800096.USD","LU1244550577.SGD","IE000BZT7R73.USD","IE0002270589.USD","LU0345770993.USD","IE0000B7K699.USD","LU1057294990.SGD","LU2471134879.HKD","XLV","LU0053666078.USD","VHT","IE000M9KFDE8.USD","LU0122379950.USD","LU2471134523.USD","SGXZ57979304.SGD","LU0882574055.USD","LU2129689605.HKD","IE00BVYPNW00.USD","BK4581","LU0912757837.SGD","LU1061106388.HKD","LU1121112475.USD","LU2456880835.USD","LU2505996509.AUD","LU0289739699.SGD","LU0345769631.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU2896262040.SGD","LU0114720955.EUR","IE00BGHQF631.EUR","LU2471134796.USD","LU2602419157.SGD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU2430703251.USD","LU1066051811.HKD","LU0162691827.USD","LU2505996681.GBP","BK4533","LU1066051225.USD","LU1221951046.USD","LU1043141123.HKD","BMED","LU1291159041.SGD","LU0072461881.USD","IE00BZ1G4Q59.USD","IYH","LU2347655156.SGD","LU0820562030.AUD","LU1244550494.USD","LU1228905540.USD","IE0001KFT4U8.USD","LU0426417589.USD","LU2468319806.SGD","LU0210528500.USD","LU0795875086.SGD","LU1894683264.USD","IE00BFXG1179.USD","LU0985320562.USD","BK4559","LU1145028129.USD","LU0466842654.USD","LU1914381329.SGD","LU1496350502.SGD","BK4550","LU1718418525.SGD","IE00BBT3K403.USD","LU2756315318.SGD","IE00BVYPNV92.GBP","LU0070217475.USD","LU1778281490.HKD","JNJ","LU0426412945.USD","LU1983299246.USD","LU1032955483.USD","LU1032466523.USD","LU1196500208.SGD","IE0034235303.USD","BK4007","LU0964807845.USD","LU2129689514.USD","LU1430594728.SGD","LU0511384066.AUD","LU2112291526.USD","LU1228905037.USD","LU1506573853.SGD","LU0234572021.USD","LU1989771016.USD","LU0098860793.USD","LU0289961442.SGD","LU0545562505.USD","LU0683600562.USD","IE00B4R5TH58.HKD","LU1267930813.SGD","LU1674673691.USD","LU0820561909.HKD","LU1074936037.SGD","BK4534","IE00B1BXHZ80.USD","IE000WAW04H5.SGD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0472753341.HKD","IE0002141913.USD","LU0234570918.USD","LU0203345920.USD","BK4588","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667902606","title":"強生試驗性抑鬱症藥物未達中期研究主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2667902606","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667902606?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 10:25","pubTimestamp":1789439104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["FHLC","GDOC","LU0069063385.USD","LU0345769128.USD","LU2129689605.HKD","LU1732799900.SGD","MEDX","LU0057025933.USD","XLV","LU0426412945.USD","LU2133065610.SGD","JNJ","BK4007","LU1244550494.USD","SG9999001176.SGD","LU2430703251.USD","IXJ","LU1280957306.USD","VHT","TRUH","IE000MB6IJN5.SGD","BMED","RXL","PJP","IYH","IHE","FTXH","LU0098860793.USD","LU1935042991.SGD","LU0432979614.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0689626769.HKD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","JDOC","LU2430703178.SGD","LU0058720904.USD","LU1914381329.SGD","LU1674673691.USD","LU0210536198.USD","LU0820561818.USD","LU2471134796.USD","LU0689472784.USD","LU0964807845.USD","LU1066051225.USD","SG9999002232.USD","IE000BZT7R73.USD","LU0683600562.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695694","title":"禮來表示，Foundayo已佔據美國口服減肥藥新患者市場的30%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695694","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695694?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:32","pubTimestamp":1789417976,"startTime":"0","endTime":"0","summary":"礼来表示，Foundayo已占据美国口服减肥药新患者市场的30%以上Mariam Sunny路透9月14日-礼来公司周一表示，其已占据美国口服减肥药市场30%以上的新患者份额，从而缩小了丹麦竞争对手诺和诺德凭借其Wegovy口服减肥药所取得的早期领先优势。诺和诺德首席执行官迈克·杜斯特达尔今年8月曾表示，尽管面临礼来公司口服减肥药Foundayo的竞争，该公司估计Wegovy口服药已占据美国口服减肥药市场约90%的份额 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S4561JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827948.USD","NVOC","LU0823416689.USD","LU0158827781.USD","LU2168564222.USD","IYH","LU2237443978.SGD","LU0174119429.USD","LU2552382215.SGD","LU2491050071.SGD","LU0097036916.USD","LU0234572021.USD","LU1629891620.HKD","SG9999014906.USD","AGNG","LU2168564149.EUR","BK4588","LU2237443549.SGD","IXJ","IE0004445239.USD","LU0882574139.USD","LU2746668974.SGD","THNR","IE00B2B36J28.USD","LU0096364046.USD","LU1127390331.HKD","LU1093756325.SGD","LU1551013425.SGD","LU0323591593.USD","LU1061106388.HKD","LU1868836591.USD","VHT","IE0004445015.USD","LU2237443382.USD","LU2471134952.CNY","BK4007","SG9999015978.USD","IE0009355771.USD","IE00BK4W5L77.USD","LU2746668461.USD","LU1267930730.SGD","SG9999001176.USD","BK4534","XLV","GB00BDT5M118.USD","LU0353189763.USD","SG9999013999.USD","LU2361045086.USD","LU0122379950.USD","LU0471298694.HKD","IE00BK4W5M84.HKD","LU1804176565.USD","LU0466842654.USD","IE00BJT1NW94.SGD","LU2023251221.USD","IHE","LU0058720904.USD","LU1868836757.USD","BK4533","IE0002141913.USD","LU1035775433.USD","LU2360106947.USD","LU0203201768.USD","LU1974910355.USD","SG9999017495.SGD","FHLC","MEDX","ELIS","TMED","LU2602419157.SGD","IE0005OL40V9.USD","LU0320765992.SGD","LU0786609619.USD","IE00BKDWB100.SGD","LLY","LU0471298777.SGD","LU0882574055.USD","LU2271345857.HKD","LU2750360641.GBP","SG9999001176.SGD","LU0316494557.USD","SG9999014898.SGD","LU2168563687.JPY","LU2461242641.AUD","LU0225283273.USD","LU0640476718.USD","LLII","IE00B4JS1V06.HKD","LU0353189680.USD","LU0683600562.USD","LU1691799644.USD","LU1868837300.USD","LU1093756168.USD","LU2237443622.USD","IE00BJLML261.HKD","LU2211815571.USD","SG9999015986.USD","LU0417517546.SGD","OZEM","SGXZ57979304.SGD","LU0345770308.USD","LU0345770993.USD","LU0079474960.USD","CANC","LU2756315664.SGD","LU0820561818.USD","LU2168564495.EUR","IE00B7KXQ091.USD","SGXZ81514606.USD","RXL","IE00BWXC8680.SGD","SG9999018865.SGD","SG9999014914.USD","IE00BJJMRZ35.SGD","LU0238689110.USD","HRTS","LU1988902786.USD","LU0256863902.USD","MHIP","LU0133085943.USD","LU0203202063.USD","IE00BFSS7M15.SGD","LU1917777945.USD","JDOC","LU0320765059.SGD","IE0001KFT4U8.USD","SG9999015945.SGD","BK4532","LU2112291526.USD","LU2324357040.USD","IE00BKVL7J92.USD","LU2168564065.EUR","SGXZ99366536.SGD","ELIL","LU0094547139.USD","LU2471134796.USD","BK4585","GDOC","LU2089283258.USD","LU2264538146.SGD","LU1323610961.USD","SGXZ31699556.SGD","LU2213496289.HKD","LU1145028129.USD","LU0006306889.USD","PPH","IE00BFSS8Q28.SGD","LU0823434583.USD","LU2471134879.HKD","LU0256863811.USD","LU2456880835.USD","IE00BJJMRY28.SGD","LU2471134523.USD","LU1232071149.USD","IE00BN29S564.USD","LU0289739699.SGD","LU2417539215.USD","NVO","LU1023059063.AUD","LU2237443465.HKD","LU0061475181.USD","LU2361044865.SGD","SG9999015952.SGD","LU2552382058.USD","LU2462591350.SGD","LU2089984988.USD","LU0109391861.USD","LU2237443895.HKD","LU0672654240.SGD","LU0943347566.SGD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU2237438978.USD","LU2361044949.HKD","LU2552382132.HKD","LU0889565916.HKD","SGXZ51526630.SGD","WDNA","LLYX","LU1983299246.USD","LU2106854487.HKD","LU0456855351.SGD","IE00BJJMRX11.SGD","LU2108987350.USD","LU2111349929.HKD","LU1366192091.USD","LU2023250504.SGD","LU1623119135.USD","LU2265009873.SGD","NVOH","LU0354030511.USD","LU1720051108.HKD","LU2236285917.USD","LU2468319806.SGD","LU1814569148.SGD","LU1280957306.USD","LU1868837136.USD","CURE","LU1989771016.USD","LU2357305700.SGD","LU2462157665.USD","LU1069344957.HKD","LU1979441026.SGD","LU2491050154.USD","BK4581","LU0708995401.HKD","LU2896262040.SGD","BK4516","LU0210536198.USD","LU0964807845.USD","LU0198837287.USD","LU2750360997.AUD","FTXH","IE00B1BXHZ80.USD","IE00B775H168.HKD","LU0689472784.USD","PJP","LU2028103732.USD","NVOX","LU0432979614.USD","LU1868836914.USD","LU0385154629.USD","LU2491049909.HKD","LU1712237335.SGD","LU0820561909.HKD","LU2023250330.USD","IE00B4R5TH58.HKD","MEDI","LU0820562030.AUD","LU1057294990.SGD","LU1291159041.SGD","LU1551013342.USD","IE00BKPKM429.USD","ILDR","LU1548497426.USD","BK4599","IE00BFTCPJ56.SGD","LU1064131342.USD","SG9999014880.SGD","LU2087625088.SGD","LU1720051017.SGD","LU0823434740.USD","LU0787776722.HKD","LU0114720955.EUR","LU0109394709.USD","LU2063271972.USD","LU2089284900.SGD","LU0106261372.USD","LU2756315318.SGD","SG9999018857.SGD","LU0354030438.USD","TRUH","LU0266013472.USD","IE00B1XK9C88.USD","LLYZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667022693","title":"Contineum與強生合作的抑鬱症藥物未能達到中期試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2667022693","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667022693?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:11","pubTimestamp":1789416695,"startTime":"0","endTime":"0","summary":"Contineum与强生合作的抑郁症药物未能达到中期试验目标路透9月14日-Contineum Therapeutics（CTNM.O）周一表示，该公司与强生公司（JNJ.N）联合研发的一种抗抑郁试验性药物未能达到中期临床试验的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4T4561IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","JNJ","IYH","MEDX","FTXH","LU2602419157.SGD","GDOC","PJP","LU1221951129.SGD","LU1066051811.HKD","SG9999001176.SGD","LU1043141123.HKD","LU1066051225.USD","IXJ","IE00B4R5TH58.HKD","LU2471134523.USD","LU0683600562.USD","LU0289739699.SGD","LU2417539215.USD","LU1291159041.SGD","LU0289739343.SGD","LU0792757196.USD","LU1267930813.SGD","VHT","LU0345770308.USD","IE00BLSP4452.SGD","LU0203347892.USD","IE00BLSP4239.USD","BMED","IE00BZ1G4Q59.USD","BK4568","LU0345769128.USD","LU1066051498.USD","RXL","XLV","IE0002270589.USD","LU0912757837.SGD","LU2592432038.USD","IE000WAW04H5.SGD","IHE","IE00B3PB1722.GBP","LU0058720904.USD","LU2430703095.HKD","TRUH","JDOC","BK4504","LU1162221912.USD","CTNM","BK4532","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RXL\",params:#limit:6,delay:false,,,undefined,":[]}}